Alpha Wave

Activity from announced rounds

Activity in this selectionOct 19, 2026 · Sep 20, 2026

Alpha Wave is the investment-manager name used in the covered financings and connected to Alpha Wave Global’s official press and investment records.

Recorded funding activity

The recorded activity includes a lead role in Moonwalk Biosciences’ Series B for medicines targeting fat-tissue pathways in obesity and cardiometabolic disease. Other announcements concern AdvanCell’s targeted alpha radiopharmaceuticals for cancer and Ultrahuman’s wearable ring and health-testing products. These events describe the activity captured here rather than the manager’s complete allocation.

Sources
Rounds participated in
1
Confirmed lead rounds
0
All roles disclosed
New companies
1
First participation on record · 0 follow-on
Funding in participating rounds
$50M
1 disclosed · full round size, not this investor’s share

By stage

Series B1

By primary sector

Healthtech1

By country

India1

Rounds

1 in this selection
Even Healthcare

Even Healthcare combines hospital care, care coordination and digital follow-up for patients in India.

$50MSeries B
Participant